샘플 요청 목록

 카트 문의
시장보고서
상품코드
1873164

세계의 바이오서저리 시장

Biosurgery
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 바이오서저리 시장은 2030년까지 184억 달러에 달할 전망

2024년에 145억 달러로 추정되는 세계의 바이오서저리 시장은 2024-2030년의 분석 기간에 CAGR 4.1%로 성장하며, 2030년까지 184억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석 대상이 된 부문의 하나인 골이식 대체재는 3.9%의 CAGR을 기록하며, 분석 기간 종료까지 72억 달러에 달할 것으로 예측됩니다. 지혈제 부문의 성장률은 분석 기간에 3.6%의 CAGR로 추정되고 있습니다.

미국 시장은 39억 달러로 추정되는 한편, 중국은 3.9%의 CAGR로 성장할 것으로 예측됩니다.

미국의 바이오서저리 시장은 2024년에 39억 달러로 추정되고 있습니다. 세계 2위의 경제 규모를 자랑하는 중국은 2024-2030년의 분석 기간에 CAGR 3.9%로 추이하며, 2030년까지 29억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역 시장으로는 일본과 캐나다를 들 수 있으며, 각각 분석 기간 중 3.7%, 3.4%의 CAGR로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 3.1%의 CAGR로 성장할 것으로 예측됩니다.

세계의 바이오서저리 시장 - 주요 동향과 촉진요인의 개요

바이오서저리란 무엇이며, 현대 의학에서 주목받는 이유

바이오서저리는 의료기술 분야에서 혁신적이고 빠르게 진화하고 있는 분야인데, 구체적으로 어떤 내용을 담고 있는가? 넓은 의미에서 바이오서저리는 외과수술을 지원하기 위해 생체 유래 또는 생체 적합성 재료를 사용하는 것을 말합니다. 이러한 재료는 인체와 원활하게 상호작용하도록 설계되어 치유를 촉진하고 합병증을 최소화하며 기존의 수술적 방법에 대한 대안을 제시하는 경우가 많습니다. 바이오 수술의 적용 범위는 지혈(출혈을 멈추는 과정), 조직 재생, 생체 조직과 일체화할 수 있는 생체활성 임플란트 사용 등 광범위합니다. 최소침습 수술에 대한 관심 증가와 회복기간 단축 및 입원일수 단축에 대한 요구가 맞물리면서 생체 수술 기술에 대한 관심이 크게 증가하고 있습니다. 전 세계 의료 시스템이 환자의 치료 결과와 비용 효율성을 중시하는 가운데, 생체 수술은 현대 외과 의료의 기반이 되는 기술로 확고한 입지를 다지고 있습니다.

첨단 기술은 바이오 수술의 미래를 어떻게 형성하고 있는가?

바이오서저리 분야는 기술의 발전으로 인해 극적으로 변모하고 있는데, 구체적으로 어떤 변화가 일어나고 있는가? 가장 중요한 발전 중 하나는 재생의료 분야로, 손상된 조직을 복구하고 대체하기 위해 스캐폴드, 성장인자 등 바이오 수술용 제품을 사용하고 있습니다. 또한 나노테크놀러지의 통합은 약물 및 기타 치료제를 수술 부위에 직접 전달할 수 있는 보다 정교한 생체 재료를 만들어 신체의 자연 치유 과정을 촉진할 수 있게 해줍니다. 로봇 공학 및 영상 기술도 중요한 역할을 하고 있으며, 수술 중 외과의사에게 전례 없는 정확성과 제어력을 제공합니다. 또한 3D 프린팅 기술의 등장으로 환자 개개인에 맞는 맞춤형 임플란트 및 이식편의 가능성이 확대되어 거부반응의 위험을 줄이고 치료 결과를 향상시키고 있습니다. 이러한 기술이 계속 발전함에 따라 바이오 수술의 잠재적 응용 범위가 확대되고 수술 수행 방식에 혁명을 가져올 것으로 예측됩니다.

복잡한 수술 사례에서 바이오서저리가 첫 번째 선택이 되고 있는 이유는 무엇인가?

복잡하고 까다로운 수술 사례에서 바이오 수술 제품의 고유한 기능이 채택을 촉진하고 있지만, 무엇이 바이오 수술 제품을 그토록 필수적인 것으로 만드는 것일까? 많은 경우, 기존의 수술 방법은 너무 침습적이거나 원하는 결과를 얻지 못하는 경우가 많으며, 특히 광범위한 조직 손상이나 섬세한 구조가 관련된 경우 더욱 그러합니다. 피브린 실란트, 콜라겐 기반 매트릭스, 합성 이식재와 같은 바이오 수술 제품은 외과 의사에게 신체의 자연 치유력을 높이고 합병증 위험을 줄이며 전체 수술 성공률을 향상시킬 수 있는 수단을 제공합니다. 예를 들어 심혈관 수술에서 바이오 수술은 혈관 수복과 과다 출혈을 예방하는 데 매우 중요한 역할을 하고 있습니다. 정형외과수술에서는 생체활성 물질이 뼈 재생 촉진 및 임플란트 통합성 향상에 활용되고 있습니다. 또한 상처 치료 분야, 특히 기존 치료법이 효과가 없는 만성 상처에서 바이오 수술의 적용 범위는 계속 확대되고 있습니다. 고령화 사회의 진전과 만성질환 증가라는 도전에 의료업계가 계속 직면하고 있는 가운데, 이러한 질환을 관리하는데 있으며, 바이오 수술의 역할은 앞으로 더욱 중요해질 것으로 보입니다.

바이오 수술 시장의 급속한 확장을 이끄는 요인은 무엇인가?

바이오서저리 시장의 성장은 여러 가지 요인에 의해 주도되고 있으며, 각 요인은 이러한 첨단 수술 솔루션에 대한 수요 증가에 기여하고 있습니다. 특히 바이오소재와 재생의료 분야의 기술 혁신은 바이오서저리의 적용범위를 크게 확대하여 다양한 의료분야에서 보다 현실적인 선택이 되고 있습니다. 또한 당뇨병, 심혈관 질환과 같은 만성질환의 유병률 증가는 기존의 방법으로는 충분하지 않은 복잡한 수술 사례 증가로 이어지고 있습니다. 소비자 행동에도 영향을 미치고 있으며, 환자들은 회복 기간이 짧고 부작용이 적은 최소침습적 수술을 점점 더 많이 찾고 있습니다. 의료진들의 바이오 수술에 대한 인식과 수용도가 높아진 것도 보급을 더욱 촉진하고 있습니다. 더 많은 임상의들이 이러한 기술이 환자의 치료 결과를 개선하는 이점을 인식하고 있기 때문입니다. 또한 세계 인구의 고령화도 바이오 수술 제품 수요에 기여하고 있습니다. 고령의 환자들은 이러한 첨단 기술의 혜택을 받을 수 있는 수술적 개입이 필요할 가능성이 높기 때문입니다. 마지막으로 특히 신흥 시장에서의 정부 지원 정책과 의료 인프라에 대한 투자 확대는 바이오 수술 시장이 발전하는 데 필요한 환경을 조성하여 이 활기찬 분야의 지속적인 성장과 혁신을 보장하고 있습니다.

부문:

제품별(골이식 대체재, 지혈제, 연조직 고정재, 수술용 실링제, 유착방지제), 용도별(일반외과, 정형외과, 성형외과, 부인과 수술, 기타 용도), 최종사용처별(병원, 클리닉, 기타 최종사용처)

조사 대상 기업의 예

  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • MAQUET Holding B.V. & Co. KG
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi U.S.
  • Stryker Corporation

AI 통합

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석 방식을 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM이나 산업 전문 SLM에 대한 쿼리 방식을 대신하여, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.

관세 영향 계수

세계 산업 분석가들이 본사 소재지, 생산기지, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하는 과정에서 지역적 시장에 대한 관세의 영향을 반영했습니다. 이러한 복잡하고 다면적인 시장 현실은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학을 통해 경쟁사들에게 영향을 미칠 것입니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계의 기타 지역

제4장 경쟁

KSA 25.11.26

Global Biosurgery Market to Reach US$18.4 Billion by 2030

The global market for Biosurgery estimated at US$14.5 Billion in the year 2024, is expected to reach US$18.4 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Bone Graft Substitutes, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the Hemostatic Agents segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.9 Billion While China is Forecast to Grow at 3.9% CAGR

The Biosurgery market in the U.S. is estimated at US$3.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 3.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Biosurgery Market - Key Trends and Drivers Summarized

What Is Biosurgery, and Why Is It Gaining Traction in Modern Medicine?

Biosurgery is an innovative and rapidly evolving field within medical technology, but what exactly does it encompass? Broadly speaking, biosurgery involves the use of biologically-based or biocompatible materials to aid in surgical procedures. These materials are engineered to interact seamlessly with the human body, promoting healing, minimizing complications, and often providing alternatives to traditional surgical methods. The scope of biosurgery is extensive, covering areas such as hemostasis (the process of stopping bleeding), tissue regeneration, and even the use of bioactive implants that can integrate with living tissues. The growing emphasis on less invasive procedures, combined with the desire for faster recovery times and reduced hospital stays, has significantly increased interest in biosurgical techniques. As healthcare systems across the globe prioritize patient outcomes and cost-effectiveness, biosurgery is poised to become a cornerstone of modern surgical practice.

How Are Cutting-Edge Technologies Shaping the Future of Biosurgery?

The landscape of biosurgery is being dramatically transformed by advancements in technology, but how exactly are these changes unfolding? One of the most significant developments has been in the field of regenerative medicine, where biosurgical products such as scaffolds and growth factors are used to facilitate the repair or replacement of damaged tissues. Additionally, the integration of nanotechnology is allowing for the creation of more sophisticated biomaterials that can deliver drugs or other therapeutic agents directly to the site of surgery, enhancing the body's natural healing processes. Robotics and imaging technologies are also playing a crucial role, providing surgeons with unprecedented precision and control during procedures. Furthermore, the advent of 3D printing is opening up new possibilities for custom implants and grafts that are tailored to individual patients, reducing the risk of rejection and improving outcomes. As these technologies continue to evolve, the potential applications of biosurgery are expanding, promising to revolutionize the way surgeries are performed.

Why Is Biosurgery Becoming the Go-To Option for Complex Surgical Cases?

The unique capabilities of biosurgical products are driving their adoption in complex and challenging surgical cases, but what makes them so indispensable? In many instances, traditional surgical methods are either too invasive or unable to achieve the desired outcomes, particularly in cases involving extensive tissue damage or delicate structures. Biosurgical products, such as fibrin sealants, collagen-based matrices, and synthetic grafts, provide surgeons with tools that can enhance the body's natural ability to heal, reduce the risk of complications, and improve the overall success rate of surgeries. For example, in cardiovascular surgery, biosurgery is playing a pivotal role in the repair of blood vessels and the prevention of excessive bleeding. In orthopedic surgery, bioactive materials are being used to promote bone regeneration and improve the integration of implants. Moreover, biosurgery is finding increasing applications in wound care, particularly in chronic wounds that are resistant to conventional treatments. As the healthcare industry continues to grapple with the challenges of an aging population and the rising prevalence of chronic diseases, the role of biosurgery in managing these conditions is set to grow.

What Is Fueling the Rapid Expansion of the Biosurgery Market?

The growth in the biosurgery market is driven by several factors, each contributing to the increasing demand for these advanced surgical solutions. Technological innovations, particularly in biomaterials and regenerative medicine, have significantly expanded the range of applications for biosurgery, making it a more viable option across various medical disciplines. Additionally, the rising prevalence of chronic diseases, such as diabetes and cardiovascular conditions, is leading to an increase in complex surgical cases where traditional methods may fall short. Consumer behavior is also playing a role, with patients increasingly seeking out minimally invasive procedures that offer quicker recovery times and fewer side effects. The growing awareness and acceptance of biosurgery among healthcare providers further drive its adoption, as more clinicians recognize the benefits of these techniques in improving patient outcomes. Moreover, the aging global population is contributing to the demand for biosurgical products, as older patients are more likely to require surgical interventions that benefit from these advanced technologies. Finally, supportive government policies and increased investment in healthcare infrastructure, particularly in emerging markets, are providing the necessary environment for the biosurgery market to thrive, ensuring continued growth and innovation in this exciting field.

SCOPE OF STUDY:

The report analyzes the Biosurgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents, Anti-Adhesion Agents); Application (General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery, Other Applications); End-Use (Hospitals, Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 12 Featured) -

  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • MAQUET Holding B.V. & Co. KG
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi U.S.
  • Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Biosurgery - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Minimally Invasive Surgeries Spurs Growth in Biosurgery Market
    • Advancements in Biomaterials and Tissue Engineering Expand Addressable Market Opportunity
    • Increased Use of Biosurgery in Cardiovascular and Orthopedic Procedures Drives Market Adoption
    • Here's How Technological Innovations in Hemostasis and Sealants Propel Market Growth
    • Growing Geriatric Population and Associated Chronic Conditions Generate Demand for Biosurgical Products
    • Emerging Applications of Biosurgery in Regenerative Medicine Sustain Long-Term Market Expansion
    • Shifts Towards Personalized Medicine and Customized Surgical Solutions Throw the Spotlight on Biosurgery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biosurgery Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Bone Graft Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Hemostatic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Soft Tissue Attachments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Soft Tissue Attachments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Soft Tissue Attachments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Surgical Sealing Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Anti-Adhesion Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for General Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Orthopedic Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Reconstructive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Reconstructive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Reconstructive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Gynecological Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Gynecological Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Gynecological Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of World 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of World 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제